InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,780.05
(
-0.21%
)
US TECH 100
19,715.20
(
-0.05%
)
Dow Jones
42,454.12
(
-0.14%
)
Brent Oil
79.06
(
3.17%
)
Bitcoin
60,178.14
(
-0.66%
)
Post# of 539
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Michel

Send PM Follow Ignore
Followers 76
Posts 10333
Boards Moderated 0
Alias Born 02/23/2010

Michel

Re: None

Wednesday, 11/04/2020 4:16:59 AM

Wednesday, November 04, 2020 4:16:59 AM

Post# of 539
Acorda Therapeutics (ACOR) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.30. This compares to loss of $0.46 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of 23.33%. A quarter ago, it was expected that this drugmaker would post a loss of $0.46 per share when it actually produced a loss of $0.35, delivering a surprise of 23.91%.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up